Here we demonstrated that the injection of nondiabetic plasma-treated SVFs into the adipose tissue of Leprdb/db mice decreased proinflammatory cytokine expression, suppressed plasma DPP4 activity and CCL2 levels, and ameliorated insulin resistance. The gene discussed is CCL2; the disease is Insulin resistance.